Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Keith Kendall Net Worth & Insider Trades

Keith Kendall - CEO and President, Aquestive Therapeutics, Inc

As of March 14, 2022

What is Keith Kendall's Net Worth?

The current estimated net worth of Aquestive Therapeutics, Inc's CEO and President, Keith Kendall, is estimated to be about $1.15M . Keith Kendall owns about 638,964 units of Aquestive Therapeutics, Inc common stock. In the last 4 years at Aquestive Therapeutics, Inc, Keith Kendall has sold an estimated value of $695.25K worth.

What is Keith Kendall's Past Insider Trading?

Keith Kendall's largest purchase order was 7,950 units , worth over $80.33K on November 26, 2018. Keith Kendall's largest sale order was 50,000 units , worth over $255.31K on June 5, 2020. In total, Keith Kendall has made about 28 transactions over 4 years of their time at Aquestive Therapeutics, Inc. Keith Kendall usually trades in March, with the busiest year in 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Keith Kendall

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Keith Kendall's' Mailing Address?

  • Mailing address is 30 Technology Drive Warren NJ 07059 NJ

What are Aquestive Therapeutics, Inc's Past Insider Trades?

Aquestive Therapeutics, Inc's most recent insider trade came on June 15, 2022 by Peter Boyd who bought 5,000 units worth $4.05K . In the last 4 years, insiders at Aquestive Therapeutics, Inc have sold an estimated value of $2.35M and bought an estimated value of $3.13M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Mark Alexander Schobel, Chief Innovation/Tech Officer,  Keith Kendall, CEO and President,  and Daniel Barber, President and CEO .

Aquestive Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...